# Tiagabine to Enhance Slow Wave Sleep in Patients With Sleep Apnea

> **NCT02387710** · PHASE2 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 18 (actual)

## Conditions studied

- Sleep Apnea, Obstructive

## Interventions

- **DRUG:** Tiagabine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02387710
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2016-06
- **Final completion:** 2016-07
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2017-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02387710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02387710, "Tiagabine to Enhance Slow Wave Sleep in Patients With Sleep Apnea". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02387710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*